Are you wondering if others with high-risk cytogenetic multiple myeloma have avoided needing a second stem cell transplant?
Many people with high-risk myeloma do manage their condition without requiring a second transplant. Treatment approaches vary widely based on individual circumstances, and newer medications and Show Full Answer
Are you wondering if others with high-risk cytogenetic multiple myeloma have avoided needing a second stem cell transplant?
Many people with high-risk myeloma do manage their condition without requiring a second transplant. Treatment approaches vary widely based on individual circumstances, and newer medications and therapies have significantly improved outcomes.
Some factors that may influence whether a second transplant is needed include:
* How well the first transplant worked and how long remission lasted
* Response to maintenance therapy after the initial transplant
* Overall health and organ function
* Availability of effective drug combinations when myeloma returns
A large study found that people who had an early stem cell transplant stayed in remission for about five and a half years on average. However, many people achieve similar overall survival by having a transplant later or using triplet therapy combinations instead.
When myeloma relapses, doctors often try different drug combinations first. Sometimes medications that worked before can be effective again, or newer treatment options may be recommended before considering another transplant.
Your oncologist will review your treatment history, the degree of relapse, and your overall health when making recommendations about whether another transplant might be beneficial for your specific situation.
April 14
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
